The Clinical Significance of Highly Purified Pig-insulin Preparations

Overview

Journal Diabetologia

Specialty Endocrinology

Date 1974 Dec 1

PMID 4474966

Citations 11

Authors

T Deckert

O O Andersen

J E Poulsen

Affiliations

Soon will be listed here.

Citing Articles

Structural principles of insulin formulation and analog design: A century of innovation.

Jarosinski M, Dhayalan B, Chen Y, Chatterjee D, Varas N, Weiss M Mol Metab. 2021; 52:101325.

PMID: 34428558 PMC: 8513154. DOI: 10.1016/j.molmet.2021.101325.

One Hundred Years of Insulin: Value Beyond Price in Type 2 Diabetes Mellitus.

Evans M, Morgan A, Bain S Diabetes Ther. 2021; 12(6):1593-1604.

PMID: 33899150 PMC: 8071610. DOI: 10.1007/s13300-021-01061-7.

The immunogenic properties of a highly purified insulin preparation.

Manning N, Drury M Ir J Med Sci. 2016; 148(1):135.

PMID: 27517404 DOI: 10.1007/BF02938066.

Twenty-four-hour metabolic profiles in diabetic children receiving insulin injections once or twice daily.

Werther G, Jenkins P, Turner R, Baum J Br Med J. 1980; 281(6237):414-8.

PMID: 7000260 PMC: 1713299. DOI: 10.1136/bmj.281.6237.414.

The new insulins. Their characteristics and clinical indications.

Home P, Alberti K Drugs. 1982; 24(5):401-13.

PMID: 6756879 DOI: 10.2165/00003495-198224050-00003.

References

JORPES J . Recrystallized insulin for diabetic patients with insulin allergy. Arch Intern Med (Chic). 1949; 83(4):363-71. DOI: 10.1001/archinte.1949.00220330003001. View

Larsson O . Studies of small vessels in patients with diabetes. A clinical, histological and immunohistochemical study of diabetic and non-diabetic subjects with special reference to the occurrence of various plasma proteins in the dermal vessel walls. Acta Med Scand Suppl. 1967; 480:1-66. View

. An insulin hazard?. Lancet. 1966; 2(7469):897-8. View

KUHNAU Jr J . [Insulin-binding capacity of the serum in diabetic patients with increased insulin need]. Verh Dtsch Ges Inn Med. 1968; 74:1133-5. View

WATSON D, VINES R . Variations in the incidence of lipodystrophy using different insulins. Med J Aust. 1973; 1(5):248-50. DOI: 10.5694/j.1326-5377.1973.tb200009.x. View

KORP W, LEVETT R . [Experiences with monocomponent insulin treatment]. Wien Klin Wochenschr. 1973; 85(18):326-30. View

DEVLIN J, Duggan M . Antibody studies in patients on mixed bovine-porcine insulins. Diabetologia. 1969; 5(3):192-4. DOI: 10.1007/BF01213679. View

Dixon K, Exon P, Hughes H . Insulin antibodies in aetiology of labile diabetes. Lancet. 1972; 1(7746):343-7. DOI: 10.1016/s0140-6736(72)92841-3. View

SCHLICHTKRULL J, Brange J, Christiansen A, HALLUND O, Heding L, Jorgensen K . Clinical aspects of insulin--antigenicity. Diabetes. 1972; 21(2 Suppl):649-56. DOI: 10.2337/diab.21.2.s649. View

10.

Hales C, Randle P . Immunoassay of insulin with insulin-antibody precipitate. Biochem J. 1963; 88:137-46. PMC: 1203862. DOI: 10.1042/bj0880137. View

11.

Berson S, Yalow R . Insulin in blood and insulin antibodies. Am J Med. 1966; 40(5):676-90. DOI: 10.1016/0002-9343(66)90148-3. View

12.

BRUNFELDT K, Deckert T . THE ANTIGENIC PROPERTIES OF PIG INSULIN. Acta Endocrinol (Copenh). 1964; 47:353-66. DOI: 10.1530/acta.0.0470353. View

13.

Wehner H, HUBER H, Kronenberg K . The glomerular basement membrane of the rabbit kidney on long-term treatment with heterologous insulin preparations of different purity. Diabetologia. 1973; 9(4):255-63. DOI: 10.1007/BF01221851. View

14.

Renold A, WINEGRAD A, Martin D . [Diabetes mellitus and the adipose tissue]. Helv Med Acta. 1957; 24(4):322-7. View

15.

Andersen O . Insulin antibody formation. II. The influence of species difference and method of administration. Acta Endocrinol (Copenh). 1973; 72(1):33-45. View

16.

Andreani D, Iavicoli M, Colletti A, Menzinger G . [Experiences in the treatment of diabetes with insulins of monocomponent (MC) and monospecies (MS) type]. Folia Endocrinol. 1972; 25(6):516-39. View

17.

Bruni B, Dalberto M, Osenda M, Ricci C, TURCO G . Clinical trial with monocomponent lente insulins. Preliminary report. Diabetologia. 1973; 9(6):492-8. DOI: 10.1007/BF00461695. View

18.

Wegmuller E, FANKHAUSER S . [Antigenicity of various depot insulin drugs for diabetics]. Helv Med Acta Suppl. 1970; :Suppl 50:130. View

19.

Andersen O . Insulin antibody formation. I. The influence of age, sex, infections, insulin dosage and regulation of diabetes. Acta Endocrinol (Copenh). 1972; 71(1):126-40. View